alea-institute/kl3m-data-sample-004-shuffled huggingface dataset:
<PAGE>



EXHIBIT 21.0

Ortep of New Jersey, Inc. - New Jersey

Ortep of Pennsylvania, Inc. - Pennsylvania

Ortep of Connecticut, Inc. - Connecticut

Petro/Crystal Corp. - New York

Maxwhale Corp. - Minnesota

Petro, Inc. - Delaware

Public Fuel Services Co., Inc. - New York

CBW Realty Corp. of Connecticut - Connecticut

Marex Corporation - Maryland

Ocennet Fuel Oil Corp. - Connecticut

A.P. Woodson Co., Inc. - District of Columbia

Star Gas Corporation - Delaware

Silgas, Inc. - Indiana

Star Gas Holdings - Delaware
From: npescherine@cox.net

To: E-OHPSCA2713.EBSA

Subject: Comment: RIN 1210-AB44

Date: Wednesday, September 07, 2011 2:24:05 PM

To Whom It May Concern:

I am writing today to ask in the strongest way possible that you rescind the unjust and coercive

mandate that all "contraceptives" and sterilization procedures be covered by private health insurance

with no co-pay to patients. If you do not reverse course I ask you to expand conscience protections for

any organizations that provide individual and group insurance and have moral or religious objections. I

strongly oppose the government forcing free insurance coverage on Americans especially for drugs and

devices that I oppose because some of these can cause an abortion (such as ella and Plan B).

I also ask you to reconsider your definition of religious employer and offer an authentic conscience

protection for any organization and business that has moral or religious objection to providing such

insurance to their employees. This legal mandate clearly violates the spirit of conscience laws which

prohibit government discrimination against those who object to various health services on moral or

religious grounds. The definition of "religious employer" in the regulation is so narrow as to only include

churches, but will still mean that a host of businesses and organizations that have conscience objections

will be required to choose between either violating their conscience or not being able to offer employees

health insurance.

Please protect the conscience rights of insurers, providers and people like me who object to being

forced by the federal government to offer or subsidize contraceptives and sterilization services, especially

when some of these drugs can take the life of early unborn children. No Americans should be forced by

the federal government to essentially subsidize services they object to. I again urge you in the strongest

way possible to reverse course and remove contraceptives and sterilizations from the list of mandatory

preventive services.

Sincerely,

Norma Pescherine

Glendale, AZ 85306
CATERPILLAR FINANCIAL SERVICES CORPORATION

POWERNOTES (SM)

With Maturities of 9 months or more from Date of Issue

 

Registration No. 333-59540

Filed Pursuant to Rule 424 (b) (3)

PRICING SUPPLEMENT NO. 089				Trade Date: 06/14/01
(To Prospectus Supplement & Prospectus dated

June 1, 2001)						Issue Date: 06/19/01
The Date of this Pricing Supplement June 14, 2001
SUBJECT TO REDEMPTION OR REPAYMENT

CUSIP									Date and terms of redemption or

or	Stated				 Interest			repayment (including any

Common	Interest		 Price to	 Discounts & Payment	Survivors		applicable regular or special

Code	Rate (1)	Maturity	Public (2)	Commissions Frequency	 Option	Yes/No	record dates)

14911QDS7 5.35%	06/15/05	100%	 1.0% Semi-Annually YES	 NO	

Principal						1st Payment	Day	

Amount		Proceeds		Dealer		 Date		Count

$1,705,000.00	$1,687,950.00	ABN AMRO Inc.	12/15/01		30/360	
 

Original Issue Discount Note:					Total Amount of OID:

____ Yes	 X No						N/A

 

 
- The interest rates on the PowerNotes (SM) may be changed by Caterpillar Financial Services Corporation from time to time, but any such change will not affect the interest rate on any PowerNotes (SM) offered prior to the effective date of the change.Prior to the date of this Pricing Supplement, $[16.273]mm principal amount of the PowerNotes (SM) were sold at interest rates then in effect. Subsequent offerings of PowerNotes (SM) will be made under a Prospectus Supplement and Prospectus dated June 1,2001.
- Expressed as a percentage of aggregate principal amount. Actual Price to Public may be less, and will be determined by prevailing market prices at the time of purchase as set forth in the confirmation sheet.
Amendment No. 3 to Employment Agreement with Henry J. Fuchs



 Exhibit 10.5 
 AMENDMENT NO. 3 TO 
 EMPLOYMENT AGREEMENT 

THIS AMENDMENT NO. 3 TO EMPLOYMENT AGREEMENT (the “Amendment”) made as of December 17, 2012 (“Effective
Date”) by and between BioMarin Pharmaceutical Inc., a Delaware corporation (the “Company”) and Henry J. Fuchs (“Employee”). 
  

	1.	This Amendment No. 3 is intended to amend and modify that certain Employment Agreement by and between the Company and Employee dated March 2, 2009 and amended on May 8,
2012 and May 24, 2012 (the “Agreement”). The Agreement, together with this Amendment, shall constitute a single agreement. Capitalized terms not otherwise defined in this Amendment shall have the meaning ascribed to such terms in
the Agreement. Except as expressly modified by this Amendment, the Agreement shall remaining full force and effect according to its terms. 

  

	2.	The defined term “Termination Compensation,” as provided in Section 7(c) of the Agreement, is hereby deleted and replaced in its entirety by the
following definition: 

 Termination Compensation. For purposes of this Agreement, the term
“Termination Compensation” shall mean: (i) one hundred fifty percent (150%) of the Employee’s then current annual base salary which shall be payable in a lump sum within forty-five (45) days after separation of employment, conditioned
on Employee executing the Company’s standard form severance and release agreement within twenty (20) days of the Employee’s termination, and shall be subject to customary withholding and other applicable payroll processes. If Employee
fails to execute and deliver the Company’s standard form severance and release agreement within twenty (20) days after the Employee’s termination, Employee will have no right to any Termination Compensation under this Agreement.

  

	3.	This Amendment No. 3 may be executed in any number of counterparts, each of which shall be deemed an original, but all of which together shall constitute one and the
same instrument. 

 IN WITNESS WHEREOF, the parties to this Amendment have executed this Amendment as of the date
first written above. 
  

									
	BIOMARIN PHARMACEUTICAL INC.	  		  	EMPLOYEE
					
	By:	 	 /s/ Jean-Jacques Bienaimé
	  		  	By:	 	 /s/ Henry J. Fuchs

	Name: Jean-Jacques Bienaimé	  		  		 	Henry J. Fuchs
	Its:      Chief Executive Officer
Exhibit
32(b)








This
Certification is being furnished and shall not be deemed “filed” for purposes of
Section 18 of the Securities Exchange Act of 1934, as amended, or otherwise
subject to the liability of that section.  This Certification shall
not be incorporated by reference into any registration statement or other
document pursuant to the Securities Act of 1933, except as otherwise stated in
such filing.








Certification
Pursuant to Section 1350 of Chapter 63


of Title
18 of the United States Code








In
connection with the Annual Report of Columbus Southern Power Company (the
“Company”) on Form 10-K (the “Report”) for the year ended December 31, 2008 as
filed with the Securities and Exchange Commission on the date hereof, I, Holly
Keller Koeppel, the chief financial officer of the Company certify pursuant to
18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley
Act of 2002 that, based on my knowledge (i) the Report fully complies with the
requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934
and (ii) the information contained in the Report fairly presents, in all
material respects, the financial condition and results of operations of the
Company.








/s/ Holly Keller
Koeppel_________


Holly
Keller Koeppel


Chief
Financial Officer








February
27, 2009








A signed
original of this written statement required by Section 906 has been provided to
American Electric Power Company, Inc. and will be retained by American Electric
Power Company, Inc. and furnished to the Securities and Exchange Commission or
its staff upon request.
IV 

110TH CONGRESS 

2D SESSION H. RES. 1506 

Recognizing the importance of the Border Patrol in combating human smuggling and commending the Department of Justice for increasing the 

rate of human smuggler prosecutions. 

IN THE HOUSE OF REPRESENTATIVES 

SEPTEMBER 25, 2008 

Mr. ISSA submitted the following resolution; which was referred to the Committee on the Judiciary, and in addition to the Committee on Homeland 

Security, for a period to be subsequently determined by the Speaker, in 

each case for consideration of such provisions as fall within the jurisdiction of the committee concerned 

RESOLUTION 

Recognizing the importance of the Border Patrol in combating human smuggling and commending the Department of Justice for increasing the rate of human smuggler prosecutions. 

Whereas human smuggling continues to threaten the United 

States as well as individuals in transport; 

Whereas human smuggling introduces numerous violent 

criminals to neighborhoods and communities in the 

United States; 

Whereas human smuggling exposes the United States to further acts of terrorism by subverting the authority of and 


rfrederick on PROD1PC67 with BILLS
2 

•HRES 1506 IH 

safety provided by United States Customs and Border 

Protection; 

Whereas individuals voluntarily being smuggled are exposed 

to tragic and dangerous conditions, many times resulting 

in their injury or death; 

Whereas countless individuals are abducted and smuggled 

against their will continuing the grotesque practice of 

human slavery; 

Whereas human smuggling is often conducted by organized 

crime and exposes Federal agents to increased danger in 

their enforcement efforts; 

Whereas United States Customs and Border Protection has, 

in the past, arrested many human smugglers only to see 

them freed by the Federal Government without prosecution; 

Whereas many of these same human smugglers are repeatedly arrested by United States Customs and Border Protection; 

Whereas such repeated encounters are extremely demoralizing 

to the Border Patrol in a time when the American public 

is putting tremendous pressure on the Border Patrol to 

do more to stop illegal border crossings; and 

Whereas Federal prosecutions of human smugglers have increased in recent months resulting in decreased repeat offenses and arrests and uplifted Border Patrol morale: 

Now, therefore, be it 

1 Resolved, That the House of Representatives— 

2 (1) reaffirms its support for the role and impor3 tance of the Border Patrol in combating human 

4 smuggling; and 


rfrederick on PROD1PC67 with BILLS
3 

•HRES 1506 IH 

1 (2) commends the Department of Justice for 

2 increasing the rate of human smuggler prosecutions 

3 and urges the Department of Justice to continue 

4 prosecuting human smugglers at a rate that will 

5 help eliminate the scourge of human smuggling. 

Æ 


rfrederick on PROD1PC67 with BILLS
ex10-1.htm


 


 


 








Exhibit 10.1




December 20, 2012












VIA FACSIMILE







Carrollton Bancorp


7151 Columbia Gateway Drive, Suite A


Columbia, MD 21046


Attention: Robert A. Altieri


Facsimile No: (410) 312-5435







Financial Services Partners Fund I, LLC


1826 Jefferson Place, NW


Washington, DC 20036


Attention: Richard Perry


Facsimile No: (202) 775-8365







Re:           Extension of Termination Date







Ladies and Gentlemen:







Reference is made to that certain Agreement and Plan of Merger (the “Agreement”), dated as of April 8, 2012, amended as of May 7, 2012, by and among Carrollton Bancorp (“Carrollton”), Jefferson Bancorp, Inc. (“Jefferson”) and Financial Services Partners Fund I, LLC.  Capitalized terms used but not defined herein shall have the respective meanings given to such terms in the Agreement.







Pursuant to Section 9.01(c) of the Agreement, Jefferson and Carrollton agree that the Termination Date is hereby extended until February 28, 2013.  Jefferson and Carrollton each acknowledge and agree that (i) the failure of the Effective Time to occur by December 31, 2012 is by reason of non-satisfaction of a condition set forth in Section 8.01(b) of the Agreement, and (ii) all other conditions in Article VIII of the Agreement have heretofore been satisfied or are capable of being satisfied by such date.


 


Except as expressly set forth herein, this letter shall not alter, modify, amend or in any way affect any of the terms, conditions, obligations, covenants or agreements contained in the Agreement, each of which shall remain in full force and effect.  The provisions set forth in Sections 10.03, 10.04 and 10.08 of the Agreement are incorporated herein by reference.







This letter may be executed in one or more counterparts, including by facsimile or electronic transmission, each of which shall be deemed an original, but all of such counterparts together shall be deemed to be one and the same agreement.


 


 


 


 


 


 


 


 


 


 


 


 


 


 


 


 


 


 




  





  











  






 


 


 


Please acknowledge your agreement to the terms and conditions hereof by executing this letter in the space provided below.








	  	
Sincerely yours,


	  	  
	  	
JEFFERSON BANCORP, INC.


	  	  
	  	  
	  	
By:  /s/ Kevin B. Cashen


	  	
Name:  Kevin B. Cashen


	  	
Title:  President and Chief Executive Officer


	  	  










ACKNOWLEDGED AND AGREED:







CARROLLTON BANCORP












By:      /s/ Robert A. Altieri


Name:  Robert A. Altieri


Title:  President and Chief Executive Officer

















FINANCIAL SERVICES PARTNERS FUND I, LLC


 


By:  Hovde Acquisition I LLC,


         its Managing Member                      












By:      /s/ Richard J. Perry, Jr.                                                                     


Name:  Richard J. Perry, Jr.


Title:  Managing Member
From: harryhig@yahoo.com

To: E-OHPSCA2713.EBSA

Subject: Comment: RIN 1210-AB44

Date: Wednesday, September 07, 2011 12:22:45 PM

To Whom It May Concern:

I am writing today to ask in the strongest way possible that you rescind the unjust and coercive

mandate that all "contraceptives" and sterilization procedures be covered by private health insurance

with no co-pay to patients. If you do not reverse course I ask you to expand conscience protections for

any organizations that provide individual and group insurance and have moral or religious objections. I

strongly oppose the government forcing free insurance coverage on Americans especially for drugs and

devices that I oppose because some of these can cause an abortion (such as ella and Plan B).

I also ask you to reconsider your definition of religious employer and offer an authentic conscience

protection for any organization and business that has moral or religious objection to providing such

insurance to their employees. This legal mandate clearly violates the spirit of conscience laws which

prohibit government discrimination against those who object to various health services on moral or

religious grounds. The definition of "religious employer" in the regulation is so narrow as to only include

churches, but will still mean that a host of businesses and organizations that have conscience objections

will be required to choose between either violating their conscience or not being able to offer employees

health insurance.

Please protect the conscience rights of insurers, providers and people like me who object to being

forced by the federal government to offer or subsidize contraceptives and sterilization services, especially

when some of these drugs can take the life of early unborn children. No Americans should be forced by

the federal government to essentially subsidize services they object to. I again urge you in the strongest

way possible to reverse course and remove contraceptives and sterilizations from the list of mandatory

preventive services.

Sincerely,

Harry Higinbotham

Salt Lake City, UT 84123
**Exhibit21**

**Subsidiariesof Registrant**

 
| Subsidiary                            | ** ** | **Jurisdiction  of Organization** |
|---------------------------------------|------------|-----------------------------------|
| Immucor Medizinische  Diagnostik GmbH |       | Germany                           |
| Immucor Italia S.r.l.                 |       | Italy                             |
| Immucor Diagnosticos  Medicos Lda.    |       | Portugal                          |
| Gamma Biologicals, Inc.               |       | United States (Texas)             |
| Dominion Biologicals  Limited         |       | Canada                            |
| Immucor, S.L.                         |       | Spain                             |
| Immucor Gamma Benelux  SPRL.          |       | Belgium                           |
| Immucor France EURL                   |       | France                            |
| Immucor-Kainos, Inc.                  |       | Japan                             |
| BCA Acquisition  Corporation          |       | United States (Georgia)           |
| Immucor Sales, Inc.                   |       | United States (Georgia)           |

 

The Company owns,directly or indirectly, 100% of each of the above entities.

 

----
CERTIFICATION PURSUANT TO 18 U.S.C. SECTION 1350 ADOPTED
            PURSUANT TO SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

In connection with the Annual Report of Cruisecam International, Inc., a Florida
corporation, (the "Company") on Form 10-KSB for the year ending September 30,
2005, as filed with the Securities and Exchange Commission on the date hereof
(the "Report"), I, D. Scott Watkins, President of the Company, certify the
following pursuant to Section 18, U.S.C. 1350, as adopted pursuant to Section
906 of the Sarbanes-Oxley Act of 2002:

1.    The Report fully complies with the requirements of Section 13(a) or 15(d)
      of the Securities Exchange Act of 1934; and

2.    The information contained in the report fairly presents, in all material
      respects, the financial condition and results of operations of the
      Company.


/s/ D. Scott Watkins
--------------------
D. Scott Watkins
President
June 5, 2006
#### The People of the State of New York *ex rel.*Jesse Carter v. Stephen B. French and others.

Decision affirmed. Opinion by

Brady, P. J.
No. 59693.

#### Robinson & Golluber, Inc., et al. *v.*United States,

protests 251857-K, etc. (New York).

*333Opinion by

Ford, J.

In accordance with stipulation of counsel that the merchandise consists of silk scarves or squares similar in all material respects to those the subject of *United States*v. *The Specialty House, Inc., Bryant & Heffernan, Inc., et al.*(42 C. C. P. A. 136, C. A. D. 585), the claim of the plaintiffs was sustained.
EXHIBIT 32.2

                    CERTIFICATION OF CHIEF FINANCIAL OFFICER
                                MARWICH II, LTD.
                       PURSUANT TO 18 U.S.C. SECTION 1350

     In connection with the Annual Report of Marwich II, Ltd. (the "Company") on
Form 10-KSB for the fiscal year ended January 31, 2006, as filed with the
Securities and Exchange Commission on the date hereof (the "Report"), I, Michael
L. Schumacher, Chief Financial Officer of the Company, certify, pursuant to 18
U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley
Act of 2002, to the best of my knowledge:

     (1) The Report fully complies with the requirements of Section 13(a) or
15(d), as applicable, of the Securities Exchange Act of 1934; and

     (2) The information contained in the Report fairly presents, in all
material respects, the financial condition and results of operations of the
Company.



/s/ Michael Schumacher
Michael Schumacher
President, Treasurer, and Chief Financial Officer
May 5, 2006






                                       14
UNPUBLISHED

UNITED STATES COURT OF APPEALS

FOR THE FOURTH CIRCUIT

No. 02-6406

UNITED STATES OF AMERICA,

Plaintiff - Appellee,

versus

FRANKLIN PAUL HUNT,

Defendant - Appellant.

Appeal from the United States District Court for the Eastern

District of North Carolina, at Raleigh. W. Earl Britt, Senior

District Judge. (CR-96-27-BR)

Submitted: June 20, 2002 Decided: June 26, 2002

Before MICHAEL and KING, Circuit Judges, and HAMILTON, Senior

Circuit Judge.

Affirmed by unpublished per curiam opinion.

Franklin Paul Hunt, Appellant Pro Se. Robert Edward Skiver,

Assistant United States Attorney, Raleigh, North Carolina, for

Appellee.

Unpublished opinions are not binding precedent in this circuit.

See Local Rule 36(c).
2

PER CURIAM:

Franklin Paul Hunt appeals the district court’s denial of a

postjudgment motion filed pursuant to Fed. R. Civ. P. 60(b). The

district court dismissed the underlying 28 U.S.C.A. § 2255 (West

Supp. 2001) motion on its merits on July 20, 1999. In November

2001, Hunt moved for relief from judgment pursuant to Fed. R. Civ.

P. 60(b).

We review denial of a Rule 60(b) motion for abuse of

discretion. United States v. Holland, 214 F.3d 523, 527 (4th Cir.

2000). Having reviewed the relevant documents and the district

court’s order denying the motion, we conclude that the court did

not abuse its discretion in denying the requested relief.

Therefore, we affirm the district court’s ruling. We dispense with

oral argument because the facts and legal contentions are

adequately presented in the materials before the court and argument

would not aid the decisional process.

AFFIRMED
<TABLE> <S> <C>

<ARTICLE> 5

<S>                             <C>
<PERIOD-TYPE>                   12-MOS
<FISCAL-YEAR-END>                          SEP-30-1999
<PERIOD-END>                               SEP-30-1999
<CASH>                                         689,801
<SECURITIES>                                   953,379
<RECEIVABLES>                                  141,665
<ALLOWANCES>                                         0
<INVENTORY>                                          0
<CURRENT-ASSETS>                             1,622,302
<PP&E>                                               0
<DEPRECIATION>                                       0
<TOTAL-ASSETS>                               2,750,124
<CURRENT-LIABILITIES>                           14,074
<BONDS>                                              0
<PREFERRED-MANDATORY>                                0
<PREFERRED>                                          0
<COMMON>                                     8,092,136
<OTHER-SE>                                   2,736,050
<TOTAL-LIABILITY-AND-EQUITY>                 2,750,124
<SALES>                                              0
<TOTAL-REVENUES>                               964,582
<CGS>                                                0
<TOTAL-COSTS>                                        0
<OTHER-EXPENSES>                               151,091
<LOSS-PROVISION>                                     0
<INTEREST-EXPENSE>                              96,402
<INCOME-PRETAX>                                909,893
<INCOME-TAX>                                   909,893
<INCOME-CONTINUING>                                  0
<DISCONTINUED>                                       0
<EXTRAORDINARY>                                      0
<CHANGES>                                            0
<NET-INCOME>                                   909,893
<EPS-BASIC>                                        .11
<EPS-DILUTED>                                      .11


</TABLE>